⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3262657 | 1.00 | CYP2D6 (0.60) | — | |
| SCHEMBL19307 | 1.00 | — | — | |
| SCHEMBL22792 | 1.00 | — | — | |
| SCHEMBL200243 | 1.00 | — | — | |
| SCHEMBL85624 | 1.00 | — | — | |
| SCHEMBL6858335 | 1.00 | CYP2D6 (0.60) | — | |
| SCHEMBL21185 | 1.00 | — | — | |
| SCHEMBL21184 | 1.00 | — | — | |
| SCHEMBL2024894 | 1.00 | — | — | |
| SCHEMBL1696134 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10995132-B2 | Optimal interstrand bridge for collagen mimics | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2021-05-04 | — | — | US | claimed |
| US-20140046054-A1 | PROCESS FOR PREPARING AMINES BY HOMOGENEOUSLY CATALYZED ALCOHOL AMINATION IN THE PRESENCE OF A COMPLEX CATALYST COMPRISING IRIDIUM AND AN AMINO ACID | BASF SE (DE) | 2014-02-13 | — | — | US | claimed |
| WO-2014023549-A1 | METHOD FOR PRODUCING AMINES BY HOMOGENEOUSLY-CATALYZED ALCOHOL AMINATION IN THE PRESENCE OF A COMPLEX CATALYST, WHICH CONTAINS IRIDIUM AND AN AMINO ACID | BASF SE (DE) | 2014-02-13 | — | — | WO | claimed |
| US-7122521-B2 | COMPRISING TRIPEPTIDE UNIT OF THE FORMULA (flp-Yaa-Gly)N, WHERE Yaa IS ANY AMINO ACID, FLP IS 4(R)-FLUORO-L-PROLINE, AND N IS AT LEAST 3; INCREASED STABILITY; STRONGER TRIPLE HELIX THAN NATIVE COLLAGEN; FOR USE SUCH AS IN ARTIFICIAL SKIN | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2006-10-17 | — | — | US | claimed |
| WO-2005000872-A2 | COLLAGEN MIMICS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2005-01-06 | — | — | WO | claimed |
| US-20050004032-A1 | Collagen mimics | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-01-06 | — | — | US | claimed |
| US-20260115261-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | SUSTAIN HOLDINGS LLC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12551525-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2026-02-17 | — | — | US | disclosed |
| US-12419936-B2 | Collagen peptide-based medicament compositions and devices and methods of production and use thereof | SUSTAIN HOLDINGS, LLC (US) | 2025-09-23 | — | — | US | disclosed |
| US-20250268974-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | SUSTAIN HOLDINGS, LLC | 2025-08-28 | — | — | US | disclosed |
| US-20250213641-A1 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | SUSTAIN HOLDINGS, LLC | 2025-07-03 | — | — | US | disclosed |
| EP-4552693-A2 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF | Sustain Holdings, LLC (US) | 2025-05-14 | — | — | EP | disclosed |
| WO-2025096630-A2 | COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND USES THEREOF | SUSTAIN HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| EP-0833633-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | Merck & Co., Inc. (US) | 1998-04-08 | — | — | EP | disclosed |
| EP-0805147-A1 | Novel N-substituted alpha aminoacid amides as calcium channel modulators | LILLY INDUSTRIES LIMITED (GB) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996039137-A1 | INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE | MERCK & CO., INC. (US) | 1996-12-12 | — | — | WO | disclosed |
| US-5552405-A | TREATMENT OF AIDS, ACTIVITY AGAINST RETROVIRUSES | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH, INC. (CA) | 1996-09-03 | — | — | US | disclosed |
| EP-0560269-B1 | Substituted pyrrolidine derivatives as HIV protease inhibitors | BIO MEGA BOEHRINGER INGELHEIM (CA) | 1995-05-31 | — | — | EP | disclosed |
| EP-0560269-A1 | Substituted pyrrolidine derivatives as HIV protease inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1993-09-15 | — | — | EP | disclosed |
| EP-0541168-A1 | HIV protease inhibitors useful for the treatment of aids | MERCK & CO. INC. (US) | 1993-05-12 | — | — | EP | disclosed |